GlassScriptPhysician profile
Daniel Sainburg
NPI 1679008932
$2,041.15
in general payments reported to CMS, 2019-2025
16 companies · $800 in 2025
The $800 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $145 · 2023: $123 · 2024: $973 · 2025: $800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,589 · Travel and Lodging: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,589.19 |
| Travel and Lodging | $307.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,014.48 | 2022-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Nevro Corp. | $252.50 | 2024 | Senza |
| Spr Therapeutics, INC | $171.49 | 2025 | Sprint Pns System |
| Vertos Medical, INC. | $125.10 | 2022-2024 | Mild Device Kit |
| Globus Medical, INC. | $70.91 | 2025 | Senza |
| Medtronic, INC. | $70.01 | 2024 | Intellis Adaptivestim |
| Electronic Waveform Lab, INC. | $61.95 | 2025 | |
| Abbott Laboratories | $56.52 | 2024 | Proclaim, Eterna |
| Scilex Pharmaceuticals INC. | $45.68 | 2022-2024 | Ztlido |
| Saluda Medical Americas, INC. | $35.53 | 2023-2024 | Evoke Scs, Evoke |
| Abbvie INC. | $33.17 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $29.69 | 2022 | |
| Biotronik Nro, INC. | $24.93 | 2023 | Biotronik |
| Depuy Synthes Sales INC. | $20.51 | 2023 | Orthovisc, Monovisc |
| Endo USA, INC. | $15.26 | 2024 | Xiaflex |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $13.42 | 2024 | Grafix, Grafix Pl, Stravix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sainburg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.